Amine pegylation methods for the preparation of site-specific protein conjugates
AssigneeAntriaBio, Inc.
InventorsMary S. Rosendahl, Sankaram B. Mantripragada
Life of this patent
Estimating the term…
Loading patent…
AssigneeAntriaBio, Inc.
InventorsMary S. Rosendahl, Sankaram B. Mantripragada
Estimating the term…
Examples include a method of making a protein-PEG conjugate. The method may include providing an aqueous protein solution. The aqueous protein solution may include a protein, a pH buffer, and a chelating agent. The chelating agent may be chosen from the group consisting of an aminopolycarboxylic acid, a hydroxyaminocarboxylic acid, an N-substituted glycine, 2-(2-amino-2-oxocthyl) aminoethane sulfonic acid (BES), and deferoxamine (DEF). The method may also include introducing sodium cyanoborohydride and a methoxy polyethylene glycol aldehyde to the aqueous protein solution. The sodium cyanoborohydride in the methoxy polyethylene glycol aldehyde may have a molar ratio ranging from about 5:1 to about 1.5:1. The method may further include reacting the methoxy polyethylene glycol aldehyde with the protein to form the protein-PEG conjugate. The pH buffer may maintain a pH of the aqueous protein solution ranging from 4.0 to 4.4 during the reaction.
A method of making a protein-PEG conjugate, the method comprising:
A method of making an insulin-PEG conjugate, the method comprising:
A method of making controlled-release microspheres containing a protein-PEG conjugate, the method comprising:
Dependencies are inferred from the claim text.